Company / Return on Assets (ROA)
PTC Therapeutics, Inc. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
23.5%
FY2025
5-year range
-33.1% / 23.5%
FY2021-FY2025
Trend
+210.5%
vs FY2024
Sector context
#8 of 213
Health Care
What the data says
Return on Assets (ROA) changed +211% YoY in FY2025, a notable deviation from the 9-year average annual change of +14%.
Based on SEC 10-K filings.
23.5% in FY2025 with a 5-year CAGR of +29.3%. Top quartile in the Health Care sector.
Improved from -33.1% to 23.5% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +49.2pp
- 5-Year Change
- +29.3pp
- 10-Year Change
- -
Sector benchmark
Top 4% in Health CareTop 4% of 213This company 23.5% Sector average -24.2%
▼
+197.5% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 210.5% year-over-year.
- Currently 47.7pp above the Health Care sector average.
- Lowest return on assets (roa) in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 23.5% | +210.5% |
| FY2024 | -21.3% | +35.5% |
| FY2023 | -33.1% | -28.6% |
| FY2022 | -25.7% | -97.9% |
| FY2021 | -13.0% | -123.8% |
| FY2020 | -5.8% | +62.6% |
| FY2019 | -15.5% | -35.4% |
| FY2018 | -11.4% | +43.3% |
| FY2017 | -20.2% | +61.8% |
| FY2016 | -52.8% | -13.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026